Question
Pharmacology Question on Pharmacology of cardiovascular system
The true statement among the following is___
A
The dose of telmisartan should be reduced in renal failure but not in hepatic failure.
B
The dose of irbesartan should be reduced in case of mild-moderate hepatic failure and renalfailure.
C
The dose of candesartan should be reduced in mild-moderate liver failure but not in renalfailure.
D
Losartan acts as a thromboxane A2 antagonist and inhibits platelate aggregation
Answer
Losartan acts as a thromboxane A2 antagonist and inhibits platelate aggregation
Explanation
Solution
The correct option is (D):Losartan acts as a thromboxane A2 antagonist and inhibits platelate aggregation